Combined geochemical and electrochemical methodology to quantify corrosion of carbon steel by bacterial activity.

International audienceThe availability of respiratory substrates, such as H2 and Fe(II,III) solid corrosion products within nuclear waste repository, will sustain the activities of hydrogen-oxidizing bacteria (HOB) and iron-reducing bacteria (IRB). This may have a direct effect on the rate of carbon steel corrosion. This study investigates the effects of Shewanella oneidensis (an HOB and IRB model organism) on the corrosion rate by looking at carbon steel dissolution in the presence of H2 as the sole electron donor. Bacterial effect is evaluated by means of geochemical and electrochemical techniques. Both showed that the corrosion rate is enhanced by a factor of 2-3 in the presence of bacteria. The geochemical experiments indicated that the composition and crystallinity of the solid corrosion products (magnetite and vivianite) are modified by bacteria. Moreover, the electrochemical experiments evidenced that the bacterial activity can be stimulated when H2 is generated in a small confinement volume. In this case, a higher corrosion rate and mineralization (vivianite) on the carbon steel surface were observed. The results suggest that the mechanism likely to influence the corrosion rate is the bioreduction of Fe(III) from magnetite coupled to the H2 oxidation

Cross-correlation of the 2XMMi catalogue with Data Release 7 of the Sloan Digital Sky Survey

The Survey Science Centre of the XMM-Newton satellite released the first incremental version of the 2XMM catalogue in August 2008 . With more than 220,000 X-ray sources, the 2XMMi was at that time the largest catalogue of X-ray sources ever published and thus constitutes an unprecedented resource for studying the high-energy properties of various classes of X-ray emitters such as AGN and stars. The advent of the 7th release of the Sloan Digital Sky Survey offers the opportunity to cross-match two major surveys and extend the spectral energy distribution of many 2XMMi sources towards the optical bands. We here present a cross-matching algorithm based on the classical likelihood ratio estimator. The method developed has the advantage of providing true probabilities of identifications without resorting to Monte-Carlo simulations. Over 30,000 2XMMi sources have SDSS counterparts with individual probabilities of identification higher than 90%. Using spectroscopic identifications from the SDSS DR7 catalogue supplemented by extraction from other catalogues, we build an identified sample from which the way the various classes of X-ray emitters gather in the multi dimensional parameter space can be analysed. We investigate two scientific use cases. In the first example we show how these multi-wavelength data can be used to search for new QSO2s. Although no specific range of observed properties allows us to identify Compton Thick QSO2s, we show that the prospects are much better for Compton Thin AGN2 and discuss several possible multi-parameter selection strategies. In a second example, we confirm the hardening of the mean X-ray spectrum with increasing X-ray luminosity on a sample of over 500 X-ray active stars and reveal that on average X-ray active M stars display bluer $g-r$ colour indexes than less active ones (abridged).Comment: Accepted for publication in A&A. The corresponding fits file can be downloaded from the XCat-DB home page (http://xcatdb.u-strasbg.fr/) (tools and data). The file also contains line information for all SDSS spectroscopic entries matching a 2XMM source. Results from the cross-correlation with the 2XMM DR3 are also available at the same location. 22 pages and 14 figure

Phase I/Phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Purpose Blinatumomab is a bispecific T-cell engager antibody construct targeting CD19 on B-cell lymphoblasts. Weevaluated the safety, pharmacokinetics, recommended dosage, and potential for efficacy of blinatumomab in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Methods This open-label study enrolled children , 18 years old with relapsed/refractory BCP-ALL in a phase I dosage-escalation part and a phase II part, using 6-week treatment cycles. Primary end points were maximum-tolerated dosage (phase I) and complete remission rate within the first two cycles (phase II). Results We treated 49 patients in phase I and 44 patients in phase II. Four patients had dose-limiting toxicities in cycle 1 (phase I). Three experienced grade 4 cytokine-release syndrome (one attributed to grade 5 cardiac failure); one had fatal respiratory failure. The maximum-tolerated dosage was 15 mg/m2d. Blinatumomab pharmacokinetics was linear across dosage levels and consistent among age groups. On the basis of the phase I data, the recommended blinatumomab dosage for children with relapsed/refractory ALL was 5 mg/m2d for the first 7 days, followed by 15 mg/m2d thereafter. Among the 70 patients who received the recommended dosage, 27 (39%; 95% CI, 27% to 51%) achieved complete remission within the first two cycles, 14 (52%) of whom achieved complete minimal residual disease response. The most frequent grade $ 3 adverse events were anemia (36%), thrombocytopenia (21%), and hypokalemia (17%). Three patients (4%) and one patient (1%) had cytokine-release syndrome of grade 3 and 4, respectively. Two patients (3%) interrupted treatment after grade 2 seizures. Conclusion This trial, which to the best of our knowledge was the first such trial in pediatrics, demonstrated antileukemic activity of single-agent blinatumomab with complete minimal residual disease response in children with relapsed/refractory BCP-ALL. Blinatumomab may represent an important new treatment option in this setting, requiring further investigation in curative indications

The effects of the interaction on the kinematics, stellar population and metallicity of AM2322-821 with Gemini/GMOS

We present an observational study about the impacts of the interactions in the kinematics, stellar populations, and oxygen abundances of the components of the galaxy pair AM\,2322-821. A fairly symmetric rotation curve for the companion (AM\,2322B) galaxy with a deprojected velocity amplitude of 110 km s$^{-1}$ was obtained, and a dynamical mass of 1.1 - 1.3 \times 10^{10} M_{\sun} within a radius of 4 kpc was estimated using this deprojected velocity. Asymmetries in the radial velocity field were detected for the companion, very likely due the interaction between the galaxies. The interaction between the main and companion galaxies was modelled using numerical N-body/hydrodynamical simulations, with the result indicating that the current stage of the system would be about 90 Myr after perigalacticum. The spatial variation in the distribution of the stellar-population components in both galaxies was analysed using the stellar population synthesis code {\sc STARLIGHT}. The companion galaxy is dominated by a very young (t $\leq 1\times10^{8}$ yr) population, with the fraction of this population to the total flux at $\lambda\, 5\,870\, \AA$, increasing outwards in the galaxy disc. On the other hand, the stellar population of AM\,2322A is heterogeneous along the slit positions observed. Spatial profiles of oxygen abundance in the gaseous phase were obtained using the diagnostic diagram R23 vs. [OIII]/[OII], where we compared the observed values with the ones obtained from photoionization models. Such gradients of oxygen abundance are significantly flatter for this pair of galaxies than in typical isolated spiral galaxies. This metallicity distribution is interpreted as the gradients having been destroyed by interaction-induced gas flows from the outer parts to the centre of the galaxyComment: accepted by MNRA

The MLL recombinome of acute leukemias in 2017

Chromosomal rearrangements of the human MLL/KMT2A gene are associated with infant, pediatric, adult and therapy-induced acute leukemias. Here we present the data obtained from 2345 acute leukemia patients. Genomic breakpoints within the MLL gene and the involved translocation partner genes (TPGs) were determined and 11 novel TPGs were identified. Thus, a total of 135 different MLL rearrangements have been identified so far, of which 94 TPGs are now characterized at the molecular level. In all, 35 out of these 94 TPGs occur recurrently, but only 9 specific gene fusions account for more than 90% of all illegitimate recombinations of the MLL gene. We observed an age-dependent breakpoint shift with breakpoints localizing within MLL intron 11 associated with acute lymphoblastic leukemia and younger patients, while breakpoints in MLL intron 9 predominate in AML or older patients. The molecular characterization of MLL breakpoints suggests different etiologies in the different age groups and allows the correlation of functional domains of the MLL gene with clinical outcome. This study provides a comprehensive analysis of the MLL recombinome in acute leukemia and demonstrates that the establishment of patient-specific chromosomal fusion sites allows the design of specific PCR primers for minimal residual disease analyses for all patients

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas

The epidermal growth factor receptor (EGFR) family, consisting of four tyrosine kinase receptors, c-erbB1-4, seems to be influential in gliomagenesis. The aim of this study was to investigate EGFR gene amplification and expression of c-erbB1-4 receptor proteins in human anaplastic astrocytomas. Formalin-fixed and paraffin-embedded sections from 31 cases were investigated by standard immunohistochemical procedures for expression of c-erbB1-4 receptor proteins using commercial antibodies. EGFR gene amplification was studied by fluorescence in situ hybridization using paraffin-embedded tissues. Two monoclonal antibodies, NCL-EGFR-384 and NCL-EGFR, were used for EGFR detection and they displayed positive immunoreactivity in 97% and 71%, respectively. For c-erbB2 detection three monoclonal antibodies, CB11, 3B5, and 5A2, were applied and they displayed positive immunoreactivity in 45%, 100%, and 52%, respectively. Positive immunostaining for c-erbB3 and c-erbB4 was encountered in 97% and 74%, respectively. The EGFR gene was amplified in 9 out of 31 tumors (29%). After adjusting for age, Karnofsky performance status, and extent of surgical resection, Cox multiple regression analysis with overall survival as the dependent variable revealed that c-erbB2 overexpression detected by the monoclonal antibody clone CB11 was a statistically significant poor prognostic factor (P = 0.004). This study shows the convenience and feasibility of immunohistochemistry when determining the expression of receptor proteins in tissue sections of human astrocytomas. The synchronous overexpression of c-erbB1-4 proteins in anaplastic astrocytomas supports their role in the pathogenesis of these tumors. Further, c-erbB2 overexpression seems to predict aggressive behaviour

The Lyman break analogue Haro 11: spatially resolved chemodynamics with VLT FLAMES

Using VLT/Fibre Large Array Multi Element Spectrograph (FLAMES) optical integral field unit observations, we present the first spatially resolved spectroscopic study of the well-known blue compact galaxy Haro 11, thought to be a local analogue to high-redshift Lyman break galaxies. Haro 11 displays complex emission line profiles, consisting of narrow (full width at half-maximum, FWHM ≲ 200 km s-1) and broad (FWHM ∼ 200–300 km s-1) components. We identify three distinct emission knots kinematically connected to one another. A chemodynamical analysis is presented, revealing that spatially resolved ionic and elemental abundances do not agree with those derived from integrated spectra across the galaxy. We conclude that this is almost certainly due to the surface brightness weighting of electron temperature in integrated spectra, leading to higher derived abundances. We find that the eastern knot has a low gas density, but a higher temperature (by ∼4000 K) and consequently an oxygen abundance ∼0.4 dex lower than the neighbouring regions. A region of enhanced N/O is found specifically in Knot C, confirming previous studies that found anomalously high N/O ratios in this system. Maps of the Wolf–Rayet (WR) feature at 4686 Å reveal large WR populations (∼900–1500 stars) in Knots A and B. The lack of WR stars in Knot C combined with an age of ∼7.4 Myr suggests that a recently completed WR phase may be responsible for the observed N/O excess. Conversely, the absence of N-enriched gas and strong WR emission in Knots A and B suggests that we are observing these regions at an epoch where stellar ejecta has yet to cool and mix with the interstellar medium